Picture of Intercept Pharmaceuticals logo

ICPT — Intercept Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: Intercept Pharmaceuticals Says If Deal Terminated Under Certain Circumstances, Co Required To Pay Alfasigma Termination Fee Equal To $34 Million

Sept 26 (Reuters) - Intercept Pharmaceuticals Inc
 ICPT.O :
    * INTERCEPT PHARMACEUTICALS - IF DEAL TERMINATED UNDER
CERTAIN
CIRCUMSTANCES, CO REQUIRED TO PAY ALFASIGMA TERMINATION FEE
EQUAL TO $34 MILLION

Further company coverage:  ICPT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Intercept Pharmaceuticals

See all news